Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 12
Submit an article Journal homepage
2,826
Views
13
CrossRef citations to date
0
Altmetric
Immunology

Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis

Qian CaiReal World Analytics, Janssen Scientific Affairs, Titusville, NJ, USACorrespondence[email protected]
,
Amanda TeepleReal World Analytics, Janssen Scientific Affairs, Titusville, NJ, USA
,
Bingcao WuReal World Analytics, Janssen Scientific Affairs, Titusville, NJ, USA
&
Erik MuserReal World Analytics, Janssen Scientific Affairs, Titusville, NJ, USA
Pages 1290-1297 | Received 11 Apr 2019, Accepted 27 Jun 2019, Published online: 12 Jul 2019

References

  • Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–516.
  • Brezinski EA, Dhillon JS, Armstrong AW. Economic burden of psoriasis in the United States: a systematic review. JAMA Dermatol. 2015;151:651–658.
  • Vanderpuye-Orgle J, Zhao Y, Lu J, et al. Evaluating the economic burden of psoriasis in the United States. J Am Acad Dermatol. 2015;72:961–967 e5.
  • Ferreira BR, Pio-Abreu JL, Reis JP, et al. Analysis of the prevalence of mental disorders in psoriasis: the relevance of psychiatric assessment in dermatology. Psychiat Danub. 2017;29:401–406.
  • Dowlatshahi EA, Wakkee M, Arends LR, et al. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134:1542–1551.
  • Dauden E, Castaneda S, Suarez C, et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27:1387–1404.
  • Fleming P, Bai JW, Pratt M, et al. The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. J Eur Acad Dermatol Venereol. 2017;31:798–807.
  • Kurd SK, Troxel AB, Crits-Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–895.
  • Feldman SR, Tian H, Gilloteau I, et al. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. BMC Health Serv Res. 2017;17:337.
  • Foster SA, Zhu B, Guo J, et al. Patient characteristics, health care resource utilization, and costs associated with treatment-regimen failure with biologics in the treatment of psoriasis. JMCP. 2016;22:396–405.
  • Ferreira BI, Abreu JL, Reis JP, et al. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol. 2016;9:36–43.
  • Connor CJ, Liu V, Fiedorowicz JG. Exploring the physiological link between psoriasis and mood disorders. Dermatol Res Pract. 2015;2015:1.
  • Han C, Lofland JH, Zhao N, et al. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol. 2011;10:843–850.
  • Griffiths CEM, Jo SJ, Naldi L, et al. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey. Br J Dermatol. 2018;179:173–181.
  • Bureau of Labor Statistics. Median Usual Weekly Earnings: United States Department of Labor; 2018 [updated October 16, 2018; cited 2018]. Available from: https://www.bls.gov/news.release/wkyeng.toc.htm
  • Soliman AM, Surrey E, Bonafede M, et al. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther. 2018;35:408–423.
  • Feldman SR, Zhao Y, Shi L, et al. Economic and comorbidity burden among patients with moderate-to-severe psoriasis. JMCP. 2015;21:874–888.
  • Weinberger H, Gbedemah M, Martinez AM, et al. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48:1308–1315.
  • Shah K, Mellars L, Changolkar A, et al. Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol. 2017;77:287–292 e4.
  • Marrie RA, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res. 2018;70:970–978.
  • Bernstein CN, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:360–368.
  • Wallace K, Zhao X, Misra R, et al. The humanistic and economic burden associated with anxiety and depression among adults with comorbid diabetes and hypertension. J Diabetes Res. 2018;2018:4842520.
  • Dobson-Belaire W, Goodfield J, Borelli R, et al. Identifying psoriasis and psoriatic arthritis patients in retrospective databases when diagnosis codes are not available: a validation study comparing medication/prescriber visit-based algorithms with diagnosis codes. Value Health. 2018;21:110–116.
  • Marrie RA, Walker JR, Graff LA, et al. Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J Psychosom Res. 2016;89:107–113.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.